Tag: arm

Darolutamide receives EU approval in third indication for patients with advanced prostate cancer

ORION CORPORATION
PRESS RELEASE
21 JULY 2025 at 10:30 EEST

the^delta prize launches ₹5.25 crore national challenge to power local foodpreneurs and advance India’s women-led development goals

BENGALURU, India, July 21, 2025 /PRNewswire/ -- the^delta prize has launched the aahaar bazaar challenge, a ₹5.25 crore nationwide incentive competition to unlock the...

World’s Largest Pollucite-Hosted Caesium Pegmatite Mineral Resource Defined at Shaakichiuwaanaan

Rigel and Vega confirmed as a major caesium discovery with potential to be a significant supply source for global markets, including the next wave of terrestrial solar technologies MONTREAL ,...

World’s Largest Pollucite-Hosted Caesium Pegmatite Mineral Resource Defined at Shaakichiuwaanaan

Rigel and Vega confirmed as a major caesium discovery with potential to be a significant supply source for global markets, including the next wave of terrestrial solar technologies MONTREAL,...

World’s Largest Pollucite-Hosted Caesium Pegmatite Mineral Resource Defined at Shaakichiuwaanaan

Rigel and Vega confirmed as a major caesium discovery with potential to be a significant supply source for global markets, including the next wave of terrestrial solar technologies MONTREAL ,...

UROGEN ALERT: Bragar Eagel & Squire, P.C. Urges Investors in UroGen Pharma (URGN) to Inquire About Their Rights in Class Action Lawsuit

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In UroGen Pharma (URGN) To Contact Him Directly To Discuss Their Options

Montfort Capital Announces Reinstatement of Trading on TSXV

TORONTO, July 18, 2025 /CNW/ - Montfort Capital Corp. (TSXV:MONT) ("Montfort" or the "Company") is pleased to announce that the TSX Venture Exchange (the...

SCORE Foundation Announces New Board Member

WASHINGTON, July 18, 2025 /PRNewswire/ -- The SCORE Foundation, the philanthropic arm of SCORE, the nation's largest network of volunteer, expert business mentors, announced today...

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

Audien Hearing Adds Chairman, Advisory Board, and Executive Team to Power Next Phase of Growth; Launches Audien Cares Initiative

No.-1 selling OTC hearing aid brand makes strategic moves to meet rising demand and increase impact SCOTTSDALE, Ariz., July 16, 2025 /PRNewswire/ -- Audien Hearing, the world's...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsArm

JNJ International Co., Ltd. to Exhibit at Automechanika Mexico 2026, Expanding Presence in Latin America

SOLIDUS FACTORY Accelerates Global Expansion Through Influencer Partnerships and K-Beauty Export Initiatives

WuXi Biologics’ Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market

Tag: arm

Darolutamide receives EU approval in third indication for patients with advanced prostate cancer

the^delta prize launches ₹5.25 crore national challenge to power local foodpreneurs and advance India’s women-led development goals

World’s Largest Pollucite-Hosted Caesium Pegmatite Mineral Resource Defined at Shaakichiuwaanaan

World’s Largest Pollucite-Hosted Caesium Pegmatite Mineral Resource Defined at Shaakichiuwaanaan

World’s Largest Pollucite-Hosted Caesium Pegmatite Mineral Resource Defined at Shaakichiuwaanaan

UROGEN ALERT: Bragar Eagel & Squire, P.C. Urges Investors in UroGen Pharma (URGN) to Inquire About Their Rights in Class Action Lawsuit

Montfort Capital Announces Reinstatement of Trading on TSXV

SCORE Foundation Announces New Board Member

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Audien Hearing Adds Chairman, Advisory Board, and Executive Team to Power Next Phase of Growth; Launches Audien Cares Initiative

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us